Paraplatin
information and resources from the National Cancer Institute
NCI Thesaurus | Paraplatin
(Other name for: carboplatin)NCI Thesaurus | Paraplatin
(Other name for: carboplatin)
carboplatin
Initial chemotherapy of advanced ovarian carcinoma in combination with other approved chemotherapeutic agents.
Bristol-Myers Squibb Jul 05 1991
carboplatin
Palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.
Bristol-Myers Squibb Mar 03 1989
|
|
|
|
news articles
Gemzar®/Paraplatin® Followed by Taxol®/Paraplatin® as Initial ... Mar 28, 2006
Cancer Consultants (press release), ...recently published in the journal Gynecologic Oncology, the chemotherapy regimen consisting of Gemzar® (gemcitabine) plus Paraplatin® (carboplatin) followed ...
Alimta® and Paraplatin® Effective and Well-Tolerated in ... Mar 22, 2006
Cancer Consultants (press release), ...article recently published in the Journal of Clinical Oncology, the treatment combination consisting of Alimta® (pemetrexed) and Paraplatin® (carboplatin) is ...
Taxol® and Paraplatin® Superior to Novantrone® for Hormone ... Mar 10, 2006
Cancer Consultants (press release), According to an article recently published in the journal Urology, treatment consisting of Taxol® (paclitaxel) and Paraplatin® (carboplatin) provides ...
Taxol® and Paraplatin® Superior to Novantrone® for Hormone ... Mar 10, 2006
Cancer Consultants (press release), Researchers from France have reported that the combination of Taxol (paclitaxel) and Paraplatin (carboplatin) is superior to Novantrone (mitoxantrone) for the ...
Updated Guidelines for Treatment of Ovarian Cancer Mar 27, 2006
Cancer Consultants (press release), ...months after stopping chemotherapy, the following chemotherapy regimens were added as treatment options: Gemzar® (gemcitabine)/Paraplatin® (carboplatin) and ...
Between 2010 and 2015 the Therapeutic Lung Cancer Drug Market is ... Mar 25, 2006
New Age Media Concepts (press release) ...erosion and three major chemotherapy drugs go off patent before 2012; Aventisi Taxotere (docetaxel), Bristol-Myers Squibbis Paraplatin (carboplatin) and Eli ...
Concurrent Radiation Therapy and Chemotherapy for Small Cell Lung ... Mar 16, 2006
Cancer Consultants (press release), 5-year survival of patients with limited small cell lung cancer (SCLC) following concurrent radiotherapy and chemotherapy with Paraplatin® (carboplatin), Taxol ...
Concurrent Radiation Therapy and Chemotherapy for Small Cell Lung ... Mar 16, 2006
Cancer Consultants (press release), According to an article recently published in the British Journal of Cancer, chemotherapy including Paraplatin® (carboplatin), Taxol® (paclitaxel), and ...
NCCN Announces Important Updates to Ovarian Cancer Clinical ... Mar 6, 2006
Genetic Engineering News, The regimens include gemcitabine (Gemzar, Lilly)/carboplatin (Paraplatin, Bristol Myers-Squibb) and carboplatin/paclitaxel (Taxol, Bristol Myers-Squibb). ...
Addition of Ellence® to Standard Chemotherapy Does Not Improve ... Mar 2, 2006
Cancer Consultants (press release), ...of Clinical Oncology, the addition of the chemotherapy agent Ellence® (epirubicin) to the standard chemotherapy regimen of Paraplatin® (carboplatin) and Taxol ...
Erbitux® Plus Gemzar®/Paraplatin® Promising for Stage IV NSCLC Dec 19, 2005
Cancer Consultants (press release), ...in the Journal of Clinical Oncology, the treatment combination consisting of Erbitux (cetuximab) plus Gemzar (gemcitabine) and Paraplatin (carboplatin) appears ...
Bristol-Myers sees growth in 2007 Dec 12, 2005
MarketWatch Bristol-Myers top-line has been hurt in recent quarters by the loss of patent exclusivities for its drugs Paraplatin and Videx, as well as increased ...
Non-Anthracycline Regimens Plus Herceptin Effective with Less ... Dec 9, 2005
Cancer Consultants (press release), 006 study) has indicated that the non-anthracycline containing chemotherapy regimen utilizing Taxotere® (docetaxel) and Paraplatin® (carboplatin) appears to ...
UPDATE 1-Bristol-Myers says cost cuts taking hold Dec 12, 2005
Reuters 2005 earnings to drop as much as 18 percent on lower sales of its cholesterol fighter Pravachol and generic competition for cancer drug Paraplatin and HIV ...
Non-Anthracycline Chemotherapy Regimen Plus Herceptin®: Effective ... Dec 13, 2005
Cancer Consultants (press release), ...phase III randomized trial reported that the non-anthracycline containing chemotherapy regimen of Taxotere® (docetaxel) and Paraplatin® (carboplatin) appears ...
|
|
